Introduction of genetically stabilized novel oral polio vaccine type 2 (nOPV2) in 2023‑24 and emerging IPV technologies—thermostable, cell-based, microneedle—are reshaping the market https://www.datamintelligence.com/research-report/polio-vaccine-market